Preclinical efficacy and toxicity studies of a highly specific chimeric anti-CD47 antibody

Preclinical efficacy and toxicity studies of a highly specific chimeric anti-CD47 antibody

Authors: Zhiqiang Xu, Jing Gao, Jingyun Yao, Teddy Yang, Dongxu Wang, Chaohui Dai & Yu Ding

Citation: Xu, Z., Gao, J., Yao, J. et al. Preclinical efficacy and toxicity studies of a highly specific chimeric anti-CD47 antibody. FEBS Open Bio. (2021). https://doi.org/10.1002/2211-5463.13084

Used in this study: double humanized B-hSIRPA/hCD47 mice

Read entire article

Share:

Back to top